Takeda Pharmaceutical (TAK) Non-Current Assets: 2018-2025

  • Takeda Pharmaceutical's Non-Current Assets fell 9.23% to $76.9 billion in Q1 2025 from the same period last year, while for Mar 2025 it was $76.9 billion, marking a year-over-year decrease of 9.23%. This contributed to the annual value of $77.0 billion for FY2025, which is 11.53% down from last year.
  • As of Q1 2025, Takeda Pharmaceutical's Non-Current Assets stood at $76.9 billion, which was down 9.23% from $84.7 billion recorded in Q1 2024.
  • Takeda Pharmaceutical's Non-Current Assets' 5-year high stood at $96.4 billion during Q1 2021, with a 5-year trough of $76.9 billion in Q1 2025.
  • For the 3-year period, Takeda Pharmaceutical's Non-Current Assets averaged around $83.0 billion, with its median value being $84.7 billion (2024).
  • As far as peak fluctuations go, Takeda Pharmaceutical's Non-Current Assets increased by 1.35% in 2021, and later decreased by 9.23% in 2025.
  • Over the past 5 years, Takeda Pharmaceutical's Non-Current Assets (Quarterly) stood at $96.4 billion in 2021, then dropped by 5.48% to $91.1 billion in 2022, then dropped by 4.05% to $87.4 billion in 2023, then decreased by 3.10% to $84.7 billion in 2024, then dropped by 9.23% to $76.9 billion in 2025.
  • Its Non-Current Assets was $76.9 billion in Q1 2025, compared to $84.7 billion in Q1 2024 and $87.4 billion in Q1 2023.